MCC Update 04-22-14
Update is an official newsletter of the Masonic Cancer Center for faculty, members, staff, colleagues, and friends. All submissions for the next issue must be sent to Sandi Sherman, firstname.lastname@example.org, by Noon on the Fridays for publication the following Tuesday.
April 22, 2014
Tuesday, April 22, 2014, 12-1 p.m., 1-125 CCRB
Inflammatory and immune response and the development of colorectal cancer
Anna Prizment, Ph.D., M.P.H.. Assistant Professor, Division of Epidemiology and Community Health, School of Public Health, University of Minnesota
This meeting will be simulcast in 450 MCRB. Shuttles to CCRB are available and may be boarded in front of Variety Club Heart Clinic on E. River Parkway. See website for details on pick-up time.
A peek at the next seminar:
April 29, 2014, 12-1 p.m., 1-125 CCRB
Aristolochic acid induced urothelial cancer: harbinger of an environmental and global iatrogenic disease
Arthur P. Grollman, M.D., Distinguished Professor, Department of Pharmacological Sciences, Stony Brook University Medical School
Host: Lisa Peterson, Ph.D.
In the news
The Masonic Cancer Center is mentioned in a Chicago Tribune story about the use of a Chinese herb known as Thunder God in treating pain from rheumatoid arthritis. A drug made from the plant wiped out pancreatic tumors in mice in research conducted by Ashok Saluja, Ph.D., Cell Signaling Program and is currently in phase I clinical trials in humans.
Heather Hirsch to join Minnesota Cancer Alliance
Heather Hirsch, program coordinator in cancer center’s education and outreach department, has accepted an exciting new position with the Minnesota Cancer Alliance. Her last day at the cancer center will be May 1st. She will be missed but it will be helpful to the cancer center to have a friend and ally at the alliance.
The following clinical trials conducted by Masonic Cancer Center members were recently opened:
Multicenter, randomized, double-blind, placebo-controlled, phase 3 trial of fulvestrant (faslodex) with or without PD-0332991 (Palbociclib) +/- Goserelin in women with hormone receptor-positive, HER2-negative metastatic breast cancer whose disease progressed after prior endocrine therapy
PI: Potter, David
COG ADVL1114 - A Phase 1 Study of Temsirolimus (CCI779, IND#61010) in Combination with Intensive Re-Induction Therapy for Children with Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkin Lymphoma
PI: Greengard, Emily
April 22, 2014: Department of Medicinal Chemistry Distinguished Lectureship
3:30 p.m., 1-450 Moos Tower
Ligand Targeted imaging and therapeutic agents for cancer
Philip S. Low, Ralph C. Corley Distinguished Professor & Director, Department of Chemistry, Purdue Center for Drug Discovery, Purdue University
April 23, 2014: Center for Drug Design Seminar Series
10:30 a.m., 2-690 Moos Tower
Harnessing an innate DNA damage pathway to prevent and treat cancer
Barbara A. Gilchrest, Professor, Department of Dermatology, Boston University School of Medicine
April 23, 2014: Cancer Biology Journal Club
12-1 p.m., 2-115 CCRB
Polly Chutnova, Schwertfeger lab, will discuss “PD-L1 Expression in Triple-Negative Breast Cancer,: Mittendorf EA, et al, Cancer Immunol Res 2014;2:361-370.
April 23, 2014: Department of Experimental and Clinical Pharmacology Seminar Series
12:20-1:10 p.m., 1-450 Moos Tower
Personalized Medicine: Research and implementation
Murray Brilliant, Director, Center for Human Genetics, Marshfield Clinic Research Foundation
April 24, 2014: Environmental Health Science Faculty Candidate Seminar
11 a.m., A301 Mayo
Application of a high-resolution mass-spectrometry-based DNA adductomics
approach for the identification of known and unknown DNA adducts in complex mixtures
Silvia Balbo, Ph.D., assistant professor candidate
April 27-30, 2014: International Conference on One Medicine One Science
The Commons Hotel, 615 Washington Ave. SE, Minneapolis, MN 55414
Hosted by the University of Minnesota College of Veterinary Medicine, Academic Health Center and the Office of the Vice President for Research in partnership with allied national and international agencies. For more information visit the website.
May 6-7, 2014: Distinguished Visiting Scholar Series on Health Disparities
Collins Airhihenbuwa, Ph.D., M.P.H., Director, Global Health and Culture Project, Department of Behavioral Health, Pennsylvania State University
May 6, 2014: Community Dialogue with Dr. Airhihenbuwa
2:30 p.m., location to be announced
May 7, 2014: Culture, Race, and Research: Negotiating the Journey Between the Head and the Heart
11:45 a.m.-1:05 p.m., Mayo Auditorium
May 20, 2014: 14th Annual BioResearch Product Faire
10 a.m.-2:30 p.m., Coffman Memorial Union, Great Hall
For more information visit the website.
September 29, 2014: SAVE THE DATE! 11th Annual Women’s Health Research Conference: Updates on Women’s Cancer Research
McNamara Alumni Center, University of Minnesota
Olufunmilayo I. Olopade, M.D., FACP, Walter L. Palmer Distinguished Service Professor of Medicine and Human Genetics; Associate Dean, Global Health; Director, Center for Clinical Cancer Genetics; University of Chicago
Co-sponsored by the Powell Center for Women’s Health and the Masonic Cancer Center. Visit the website for more information.
Visit the Education and Training Opportunities web page for more conference and special lecture listings.
May 9, 2014: Hippocrates Cafe: The Sarcoma Journey
6:30 p.m., Mill City Clinic, 901 S. Second St., Suite A, Minneapolis, MN 55415; $20 per person
Join us for an evening, May 9, 2014 at 6:30 p.m., when Hippocrates Cafe productions use professional actors and musicians to explore complex healthcare topics. The Sarcoma Stories performance and exhibit will explore the human side of being a sarcoma patient, family member, friend or healthcare giver.
Creator and producer of Hippocrates Cafe, Dr. Hallberg is an assistant professor in family medicine at the University of Minnesota, medical director at Mill City Clinic and a medical commentator for Minnesota Public Radio. Registration is limited to 100 participants. To register visit the website.
May 17, 2014: Register today! Cancer Survivorship Series
8 a.m.-1 p.m., McNamara Alumni Center, University of Minnesota, 200 Oak Street, SE, Minneapolis, MN 55455
The 2014 Cancer Survivorship Conference will focus on questions and issues survivors and their families often face after cancer treatment or following stem-cell transplantation. The emphasis is on educating and empowering survivors so they are better able to advocate for themselves and lead full and productive lives. Join us for this educational conference which will focus on exercise and wellness for the cancer survivor. Read more.
Visit the Community Events and Outreach page for more information.
News & Notices
Significant Change in NIH Application Resubmission Policy
NIH has just announced a significant change in its policy for resubmission applications. Effective immediately, for application due dates after April 16, 2014, following an unsuccessful resubmission (A1) application, applicants may submit the same idea as a new (A0) application for the next appropriate due date. NIH will not assess the similarity of the science in the new (A0) application to any previously reviewed submission when accepting an application for review.
NIH’s policy for accepting overlapping applications remains in effect (see NOT-OD-09-100), so it will not accept duplicate or highly overlapping applications under review at the same time.
New Investigator Pre-K Career Development Program
Sponsor: Clinical and Translational Science Institute
Funding: $52,000/yr for two years.
This career development program from the Clinical and Translational Science Institute provides mentorship, training and funds to assistant professors (in rank ≤ 4 years) interested in clinical or translational research. Awardees will receive $52,000 in research and travel funds, an individualized educational and training plan, and ongoing support from a mentor and CTSI’s Research Education, Training, and Career Development team. The two-year program provides a career development infrastructure that puts new investigators on the path to be
competitive for NIH K awards.
Applications are due May 15, 2014 by 5 p.m. Learn more and apply: http://www.ctsi.umn.edu/education/programsopportunities/pre-k/
Prospective applicants are invited to a panel discussion about the program featuring CTSI-Ed Director Jas Ahluwalia, M.D., M.P.H., and current scholars:
Friday, April 25, 2014
717 Delaware St. SE, Room 245
RSVP by Thursday, April 24 to email@example.com to reserve a lunch.
Visit the Funding Opportunities Web page to see listings previously published in Update. A list of organizations that provide funding for cancer research is also provided there.